MedTrace Logo

Antioxidant Bioavailability

NCT04463030 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2022-09-27

No results posted yet for this study

Summary

A small cross-over trial on 3 different doses of liposomal vitamin C, comparing vitamin C uptake and downstream effects when 24 people consume 1, 2, and 5 grams on different test days, compared to placebo.

Conditions

  • Pharmacokinetics

Interventions

DIETARY_SUPPLEMENT

Liposomal vitamin C, 1 gram

after a blood draw 1 gram of vitamin c will be consumed followed by 3 additional blood draws

DIETARY_SUPPLEMENT

Liposomal vitamin C, 2 grams

after a blood draw 2 grams of vitamin c will be consumed followed by 3 additional blood draws

DIETARY_SUPPLEMENT

Liposomal vitamin C, 5 grams

after a blood draw 5 grams of vitamin c will be consumed followed by 3 additional blood draws

DIETARY_SUPPLEMENT

Placebo

after a blood draw placebo will be consumed followed by 3 additional blood draws

Sponsors & Collaborators

  • Natural Immune Systems Inc

    lead OTHER

Principal Investigators

  • Gitte Jensen, PhD · NIS Labs

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2022-12-25
Completion
2023-06-25

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04463030 on ClinicalTrials.gov